These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29574423)

  • 1. Palliative stenting for oesophagogastric cancer: tumour and host factors and prognosis.
    Park JH; Woodley N; McMillan DC; Glen P
    BMJ Support Palliat Care; 2019 Sep; 9(3):332-339. PubMed ID: 29574423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Modified Glasgow Prognostic Score in Advanced Cancer Patients Receiving Palliative Care.
    Pantano Nde P; Paiva BS; Hui D; Paiva CE
    J Pain Symptom Manage; 2016 Feb; 51(2):270-7. PubMed ID: 26598040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: endoscopic stenting versus surgery.
    No JH; Kim SW; Lim CH; Kim JS; Cho YK; Park JM; Lee IS; Choi MG; Choi KY
    Gastrointest Endosc; 2013 Jul; 78(1):55-62. PubMed ID: 23522025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of stent dysfunction after self-expandable metal stent placement for malignant gastric outlet obstruction: tumor ingrowth in uncovered stents and migration of covered stents.
    Hori Y; Naitoh I; Hayashi K; Ban T; Natsume M; Okumura F; Nakazawa T; Takada H; Hirano A; Jinno N; Togawa S; Ando T; Kataoka H; Joh T
    Surg Endosc; 2017 Oct; 31(10):4165-4173. PubMed ID: 28281116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.
    Haj Mohammad N; Bernards N; van Putten M; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
    Eur J Cancer; 2017 Jun; 78():28-36. PubMed ID: 28412586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer.
    Lecleire S; Di Fiore F; Antonietti M; Ben Soussan E; Hellot MF; Grigioni S; Déchelotte P; Lerebours E; Michel P; Ducrotté P
    Gastrointest Endosc; 2006 Oct; 64(4):479-84. PubMed ID: 16996335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decade of day-case endoscopically guided stent placement in malignant oesophagogastric strictures.
    Almond LM; Patel K; Keast L; Hodson J; Nijjar R; Wilson PG; Richardson M; Singhal R
    Surg Endosc; 2017 May; 31(5):2280-2286. PubMed ID: 27613547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative use of self-expanding metal stents in initially anticancer treatment-intolerant patients with esophageal cancer.
    Furuta M; Hayashi K; Watanabe M; Hama T; Onishi M; Furusawa K; Inokuchi Y; Notsu A; Machida N; Furuse J; Maeda S
    BMC Gastroenterol; 2024 Aug; 24(1):264. PubMed ID: 39143477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative gastrojejunostomy versus endoscopic stent placement for gastric outlet obstruction in patients with unresectable gastric cancer: a propensity score-matched analysis.
    Jang SH; Lee H; Min BH; Kim SM; Kim HS; Carriere KC; Min YW; Lee JH; Kim JJ
    Surg Endosc; 2017 Oct; 31(10):4217-4223. PubMed ID: 28281127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative interventions for patients with incurable locally advanced or metastatic thoracic esophageal carcinoma.
    Kakuta T; Kosugi SI; Ichikawa H; Hanyu T; Ishikawa T; Kanda T; Wakai T
    Esophagus; 2019 Jul; 16(3):278-284. PubMed ID: 30949884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.
    Hwang JE; Kim HN; Kim DE; Choi HJ; Jung SH; Shim HJ; Bae WK; Hwang EC; Cho SH; Chung IJ
    BMC Cancer; 2011 Nov; 11():489. PubMed ID: 22103888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
    Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
    J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of palliation for unresectable colorectal cancer obstruction in patients with good performance status: endoscopic stent versus surgery.
    Ahn HJ; Kim SW; Lee SW; Lee SW; Lim CH; Kim JS; Cho YK; Park JM; Lee IS; Choi MG
    Surg Endosc; 2016 Nov; 30(11):4765-4775. PubMed ID: 26895922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and risk factors assessment for adverse events in advanced esophageal cancer patients after self-expanding metal stents placement.
    Rodrigues-Pinto E; Pereira P; Coelho R; Andrade P; Ribeiro A; Lopes S; Moutinho-Ribeiro P; Macedo G
    Dis Esophagus; 2017 Feb; 30(3):1-6. PubMed ID: 27629280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.
    Skipworth RJ; Deans DA; Tan BH; Sangster K; Paterson-Brown S; Brown DA; Hunter M; Breit SN; Ross JA; Fearon KC
    Br J Cancer; 2010 Feb; 102(4):665-72. PubMed ID: 20104227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pre-treatment clinical prognostic factors in patients with gastro-oesophageal cancer and proposal of a new staging system.
    Crumley AB; Stuart RC; McKernan M; Going JJ; Shearer CJ; McMillan DC
    J Gastrointest Surg; 2010 May; 14(5):781-7. PubMed ID: 20148314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.
    Crumley AB; McMillan DC; McKernan M; Going JJ; Shearer CJ; Stuart RC
    Br J Cancer; 2006 Jun; 94(11):1568-71. PubMed ID: 16685271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma.
    Wen J; Bedford M; Begum R; Mitchell H; Hodson J; Whiting J; Griffiths E
    J Surg Oncol; 2018 Jun; 117(8):1697-1707. PubMed ID: 29761518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of esophageal stents in patients with malignant esophageal obstruction according to palliative additional treatment.
    Kim JY; Kim SG; Lim JH; Im JP; Kim JS; Jung HC
    J Dig Dis; 2015 Oct; 16(10):575-84. PubMed ID: 26316005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping self-expandable metallic stent for palliation of a long (>10 cm) malignant gastroduodenal obstruction.
    Tsauo J; Yoo MW; Park JH; Song HY; Jun EJ; Cho YC; Kim GB
    Acta Radiol; 2017 May; 58(5):565-572. PubMed ID: 27687252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.